SEI Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

SEI Investments’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$153K	Buy	+63,937	New	+$125K	﹤0.01%	3107
2020 Q4	–	Sell	-146,020	Closed	-$210K	–	2502
2020 Q3	$210K	Hold	146,020	–	–	﹤0.01%	2226
2020 Q2	$291K	Buy	+146,020	New	+$286K	﹤0.01%	2099
2018 Q3	–	Sell	-73	Closed	-$1K	–	3034
2018 Q2	$1K	Sell	73 -117	-62%	-$1.2K	﹤0.01%	3483
2018 Q1	$1K	Buy	190 +145	+322%	+$1.34K	﹤0.01%	3335
2017 Q4	$0	Hold	45	–	–	﹤0.01%	3421
2017 Q3	$1K	Hold	45	–	–	﹤0.01%	3086
2017 Q2	$1K	Hold	45	–	–	﹤0.01%	2954
2017 Q1	$1K	Hold	45	–	–	﹤0.01%	2813
2016 Q4	$1K	Sell	45 -152	-77%	-$2.44K	﹤0.01%	2813
2016 Q3	$4K	Sell	197 -581	-75%	-$9.35K	﹤0.01%	2563
2016 Q2	$11K	Buy	778 +722	+1,289%	+$9.79K	﹤0.01%	2253
2016 Q1	$1K	Buy	+56	New	+$587	﹤0.01%	2435

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SEI Investments's LXRX Position: Q2 2026 in Review

SEI Investments opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 63,937 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #3107 among its holdings. This is a return to the name: SEI Investments previously reported a position in LXRX as recently as Q3 2020.

SEI Investments first reported a position in LXRX in Q1 2016 and has held it in 13 quarters since. The position peaked at $291K in Q2 2020. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

SEI Investments held 63,937 shares of Lexicon Pharmaceuticals worth $153K as of Q2 2026.
Lexicon Pharmaceuticals was a new SEI Investments position in Q2 2026.
Lexicon Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3107 holding.
SEI Investments first reported a position in Lexicon Pharmaceuticals in Q1 2016 and has held it in 13 quarters since.
SEI Investments's Lexicon Pharmaceuticals position peaked at $291K in Q2 2020.
149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.